1
|
Finazzi S, Paci G, Antiga L, Brissy O, Carrara G, Crespi D, Csato G, Csomos A, Duek O, Facchinetti S, Fleming J, Garbero E, Gianni M, Gradisek P, Kaps R, Kyprianou T, Lazar I, Mikaszewska-Sokolewicz M, Mondini M, Nattino G, Olivieri C, Poole D, Previtali C, Radrizzani D, Rossi C, Skurzak S, Tavola M, Xirouchaki N, Bertolini G. PROSAFE: a European endeavor to improve quality of critical care medicine in seven countries. Minerva Anestesiol 2021; 86:1305-1320. [PMID: 33337119 DOI: 10.23736/s0375-9393.20.14112-9] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
BACKGROUND Long-lasting shared research databases are an important source of epidemiological information and can promote comparison between different healthcare services. Here we present PROSAFE, an advanced international research network in intensive care medicine, with the focus on assessing and improving the quality of care. The project involved 343 ICUs in seven countries. All patients admitted to the ICU were eligible for data collection. METHODS The PROSAFE network collected data using the same electronic case report form translated into the corresponding languages. A complex, multidimensional validation system was implemented to ensure maximum data quality. Individual and aggregate reports by country, region, and ICU type were prepared annually. A web-based data-sharing system allowed participants to autonomously perform different analyses on both own data and the entire database. RESULTS The final analysis was restricted to 262 general ICUs and 432,223 adult patients, mostly admitted to Italian units, where a research network had been active since 1991. Organization of critical care medicine in the seven countries was relatively similar, in terms of staffing, case mix and procedures, suggesting a common understanding of the role of critical care medicine. Conversely, ICU equipment differed, and patient outcomes showed wide variations among countries. CONCLUSIONS PROSAFE is a permanent, stable, open access, multilingual database for clinical benchmarking, ICU self-evaluation and research within and across countries, which offers a unique opportunity to improve the quality of critical care. Its entry into routine clinical practice on a voluntary basis is testimony to the success and viability of the endeavor.
Collapse
Affiliation(s)
- Stefano Finazzi
- GiViTI Coordinating Center, Institute for Pharmacological Research Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo and Cele Daccò, Ranica, Bergamo, Italy
| | - Giulia Paci
- GiViTI Coordinating Center, Institute for Pharmacological Research Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo and Cele Daccò, Ranica, Bergamo, Italy
| | | | - Obou Brissy
- GiViTI Coordinating Center, Institute for Pharmacological Research Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo and Cele Daccò, Ranica, Bergamo, Italy
| | - Greta Carrara
- GiViTI Coordinating Center, Institute for Pharmacological Research Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo and Cele Daccò, Ranica, Bergamo, Italy
| | - Daniele Crespi
- GiViTI Coordinating Center, Institute for Pharmacological Research Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo and Cele Daccò, Ranica, Bergamo, Italy
| | | | - Akos Csomos
- Hungarian Army Medical Center, Budapest, Hungary
| | - Or Duek
- Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel
| | | | - Joanne Fleming
- GiViTI Coordinating Center, Institute for Pharmacological Research Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo and Cele Daccò, Ranica, Bergamo, Italy
| | - Elena Garbero
- GiViTI Coordinating Center, Institute for Pharmacological Research Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo and Cele Daccò, Ranica, Bergamo, Italy -
| | - Massimo Gianni
- Department of Anesthesiology and Intensive Care, Regional Valle d'Aosta Hospital, Aosta, Italy
| | | | - Rafael Kaps
- General Hospital Novo Mesto, Novo Mesto, Slovenia
| | | | - Isaac Lazar
- Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel
| | | | - Matteo Mondini
- GiViTI Coordinating Center, Institute for Pharmacological Research Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo and Cele Daccò, Ranica, Bergamo, Italy
| | - Giovanni Nattino
- GiViTI Coordinating Center, Institute for Pharmacological Research Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo and Cele Daccò, Ranica, Bergamo, Italy.,Division of Biostatistics, The Ohio State University, Columbus, OH, USA
| | - Carlo Olivieri
- Department of Anesthesiology and Intensive Care, ASL Vercelli, Vercelli, Italy
| | - Daniele Poole
- Department of Anesthesiology and Intensive Care, San Martino Hospital, Belluno, Italy
| | - Claudio Previtali
- GiViTI Coordinating Center, Institute for Pharmacological Research Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo and Cele Daccò, Ranica, Bergamo, Italy
| | - Danilo Radrizzani
- Department of Anesthesiology and Intensive Care, Hospital of Legnano, Legnano, Milan, Italy
| | - Carlotta Rossi
- GiViTI Coordinating Center, Institute for Pharmacological Research Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo and Cele Daccò, Ranica, Bergamo, Italy
| | - Stefano Skurzak
- Department of Anesthesiology and Intensive Care, San Giovanni Battista Hospital, Turin, Italy
| | - Mario Tavola
- Department of Anesthesiology and Intensive Care, ASST Lecco, Lecco, Italy
| | | | - Guido Bertolini
- GiViTI Coordinating Center, Institute for Pharmacological Research Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo and Cele Daccò, Ranica, Bergamo, Italy
| | | |
Collapse
|
2
|
Yuksel M, Gonul S, Laleci Erturkmen GB, Sinaci AA, Invernizzi P, Facchinetti S, Migliavacca A, Bergvall T, Depraetere K, De Roo J. An Interoperability Platform Enabling Reuse of Electronic Health Records for Signal Verification Studies. Biomed Res Int 2016; 2016:6741418. [PMID: 27123451 PMCID: PMC4830705 DOI: 10.1155/2016/6741418] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/12/2015] [Accepted: 10/04/2015] [Indexed: 01/17/2023]
Abstract
Depending mostly on voluntarily sent spontaneous reports, pharmacovigilance studies are hampered by low quantity and quality of patient data. Our objective is to improve postmarket safety studies by enabling safety analysts to seamlessly access a wide range of EHR sources for collecting deidentified medical data sets of selected patient populations and tracing the reported incidents back to original EHRs. We have developed an ontological framework where EHR sources and target clinical research systems can continue using their own local data models, interfaces, and terminology systems, while structural interoperability and Semantic Interoperability are handled through rule-based reasoning on formal representations of different models and terminology systems maintained in the SALUS Semantic Resource Set. SALUS Common Information Model at the core of this set acts as the common mediator. We demonstrate the capabilities of our framework through one of the SALUS safety analysis tools, namely, the Case Series Characterization Tool, which have been deployed on top of regional EHR Data Warehouse of the Lombardy Region containing about 1 billion records from 16 million patients and validated by several pharmacovigilance researchers with real-life cases. The results confirm significant improvements in signal detection and evaluation compared to traditional methods with the missing background information.
Collapse
Affiliation(s)
- Mustafa Yuksel
- SRDC Software Research & Development and Consultancy Ltd., 06800 Ankara, Turkey
| | - Suat Gonul
- SRDC Software Research & Development and Consultancy Ltd., 06800 Ankara, Turkey
- Department of Computer Engineering, Middle East Technical University, 06800 Ankara, Turkey
| | | | - Ali Anil Sinaci
- SRDC Software Research & Development and Consultancy Ltd., 06800 Ankara, Turkey
| | - Paolo Invernizzi
- Lombardia Informatica S.p.A., Via Torquato Taramelli, 26 20124 Milano, Italy
| | - Sara Facchinetti
- Lombardia Informatica S.p.A., Via Torquato Taramelli, 26 20124 Milano, Italy
| | - Andrea Migliavacca
- Lombardia Informatica S.p.A., Via Torquato Taramelli, 26 20124 Milano, Italy
| | - Tomas Bergvall
- WHO Collaborating Centre for International Drug Monitoring, Uppsala Monitoring Centre (UMC), 753 20 Uppsala, Sweden
| | - Kristof Depraetere
- Advanced Clinical Applications Research Group, Agfa HealthCare, 9000 Gent, Belgium
| | - Jos De Roo
- Advanced Clinical Applications Research Group, Agfa HealthCare, 9000 Gent, Belgium
| |
Collapse
|
4
|
Siri L, Battaglia FM, Tessa A, Rossi A, Rocco MD, Facchinetti S, Mascaretti M, Santorelli FM, Veneselli E, Biancheri R. Cognitive profile in spastic paraplegia with thin corpus callosum and mutations in SPG11. Neuropediatrics 2010; 41:35-8. [PMID: 20571989 DOI: 10.1055/s-0030-1253352] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
Autosomal recessive hereditary spastic paraplegia with thinning of the anterior corpus callosum (ARHSP-TCC) due to mutations in SPG11 on chromosome 15q (MIM610844) is the single most common cause of ARHSP. It is characterized by slowly progressive paraparesis and peripheral neuropathy. Although cognitive impairment, sometimes diagnosed as mental retardation, is an almost invariable feature, the extent and specific neuropsychological features are not fully understood. We report a comprehensive neuropsychological assessment in two ARHSP-TCC patients harbouring mutations in SPG11. A specific impairment in executive functions occurring even before cognitive decline, may be considered the core of the neuropsychological profile of patients harbouring mutations in SPG11.
Collapse
Affiliation(s)
- L Siri
- Child Neurology and Psychiatry Unit, G. Gaslini Institute and University of Genova, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|